PT  - JOURNAL ARTICLE
AU  - Denise Campbell-Scherer
TI  - Semaglutide is non-inferior to placebo for cardiovascular outcomes in patients with type 2 diabetes
AID  - 10.1136/ebmed-2016-110652
DP  - 2017 Apr 01
TA  - Evidence Based Medicine
PG  - 57--58
VI  - 22
IP  - 2
4099  - http://ebm.bmj.com/content/22/2/57.short
4100  - http://ebm.bmj.com/content/22/2/57.full
SO  - Evid Based Med2017 Apr 01; 22